Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.
Global Burden Related to Nitrous Oxide Exposure in Medical and Recreational Settings: An Individual Patient Data Meta-Analysis
40 Pages Posted: 6 Jan 2019
More...Abstract
Background: The risk of adverse effects of nitrous oxide (N2O) exposure is insufficiently recognised despite its widespread use. These effects are mainly reported through case reports.
Methods: We conducted an individual patient data meta-analysis to assess the prevalence of clinical, laboratory, and magnetic resonance findings in association with N2O exposure in medical and recreational settings. We calculated the pooled estimates for the studied outcomes and assessed the potential bias related to population stratification using principal component analysis.
Findings: Eighty-five publications met the inclusion criteria and reported on 100 patients with a median age of 27 years and 57% of recreational users. The most frequent outcomes were subacute combined degeneration (28%), myelopathy (26%), and generalised demyelinating polyneuropathy (23%). A T2 signal hyperintensity in the spinal cord was reported in 68% (57·2%-78·8%) of patients. The most frequent clinical manifestations included paraesthesia (80%; 72·0%-88·0%), unsteady gait (58%; 48·2%-67·8%), and weakness (43%; 33·1%-52·9%). At least one haematological abnormality was retrieved in 71·7% (59·9%-83·4%) of patients. Most patients had vitamin B12 deficiency: vitamin B12 <150 pmol/L (70·7%; 60·7%-80·8%), homocysteine >15 µmol/L (90·3%; 79·3%-100%), and methylmalonic acid >0·4 µmol/L (93·8%; 80·4%-100%).
Interpretation: N2O can produce severe outcomes, with neurological or haematological disorders in almost all published cases. More than half of them are reported in the setting of recreational use. The N2O-related burden is dominated by vitamin B12 deficiency. This highlights the need to evaluate whether correcting B12 deficiency would prevent N2O-related toxicity, particularly in countries with a high prevalence of B12 deficiency.
Funding Statement: INSERM UMR_S 1256.
Declaration of Interest: Authors declare no conflict of interest
Keywords: Nitrous Oxide Exposure; Individual Patient Data Meta-Analysis; Medical and Recreational Settings; N2O-related toxicity; Vitamin B12 deficiency.
Suggested Citation: Suggested Citation